Vol 2007, No 85 (2007)

Table of Contents

Cartoons

Adverse effect jpg
Business Review Editor

Research & Development

Nycomed and Micromet to Collaborate on Antibody Development Abstract pdf
Business Review Editor
Lexicon Forms Development and Financing Agreement with Symphony Capital Abstract pdf
Business Review Editor

Features

Amgen's Reality Check Abstract pdf
Business Review Editor
The Bioterrorism Threat: Smallpox Vaccine Stockpiling Abstract pdf
Business Review Editor
How Companies Source Their Licensing Opportunities, Part II: The Importance of Personal Networks Abstract pdf
Business Review Editor
Therapy Focus: Osteoporosis Abstract pdf
Business Review Editor

Licensing

Synosia Licenses Parkinson’s Compound from Syngenta Abstract pdf
Business Review Editor
Novacea Licences Cancer Therapy to Schering-Plough for US$452 M Abstract pdf
Business Review Editor

General

The Therapeutic Use of Cannabinoids Abstract
Business Review Editor

Company Profile

Intendis GmbH Abstract
Business Review Editor

Business Commentaries

Europe United? Abstract html
Fintan Walton

Deal Trackers

Arbelic (telavancin) Abstract pdf
Business Review Editor

Mergers & Acquisitions

Private Equity Consortium Buys Out Biomet with Sweetened Offer Abstract pdf
Business Review Editor
Genzyme to Acquire Bioenvision Abstract pdf
Business Review Editor


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.